Skip to content
★ Sign in to follow
RC
Total declarations
25
Company
1
▲ Purchases (11 ops.)
€49k
▼ Sales (2 ops.)
€66k

Latest filing published 27 Jan 2010 for INSULET CORP, €1,163.

Insider track record

Disclosed buys
11
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
11
Positive at T+90
83%
Median T+90
+47.6%

Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 03 Dec 2008 · 6550 days ago · €3,492
    +90.0%
    Entry US$6.51 · Close at T+365 US$12.37
  • Filed 02 Dec 2008 · 6551 days ago · €6,985
    +99.2%
    Entry US$6.07 · Close at T+365 US$12.09
  • Filed 24 Nov 2008 · 6559 days ago · €8,682
    +151.4%
    Entry US$4.90 · Close at T+365 US$12.32

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Robert Campbell: trading record in brief

All filings by Robert Campbell on record concern Insulet Corp. In total, 25 filings cover trades dated from 7 January 2008 to 25 January 2010.

On the open market, the record shows 11 purchases worth €49k and 2 sales worth €66k. Sales outweigh purchases by €18k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 12 option exercises.

A typical purchase (the median) is worth €2,894. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 83% of cases; the median change was +47.6%. These figures describe past trades and do not predict future prices.

On 27 January 2010 came the latest disclosure, an option exercise for €1,163 in Insulet Corp. The last purchase on record was published on 3 February 2009, which is 6,488 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert Campbell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    1,645 USD0SEC
    277 shares@ US$5.94Common StockSEC:0001127602-10-002332:0
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    13,270 USD0SEC
    1,140 shares@ US$11.64Common StockSEC:0001127602-10-002332:1
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    508 USD0SEC
    179 shares@ US$2.84Common StockSEC:0001127602-09-014345:0
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    2,142 USD0SEC
    595 shares@ US$3.60Common StockSEC:0001127602-09-014345:1
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    2,115 USD0SEC
    356 shares@ US$5.94Common StockSEC:0001127602-09-014345:2
  • ▲
    Vice President for ClinicalExecutivesInsulet Corp
    4,400 USD0SEC
    1,000 shares@ US$4.40Common StockSEC:0001209191-08-063893:0
    Canonical exit: 1 Mar 2009 (T+90)
  • ▲
    Vice President for ClinicalExecutivesInsulet Corp
    8,800 USD0SEC
    2,000 shares@ US$4.40Common StockSEC:0001209191-08-063564:0
    Canonical exit: 1 Mar 2009 (T+90)
  • ▲
    Vice President for ClinicalExecutivesInsulet Corp
    10,800 USD0SEC
    3,000 shares@ US$3.60Common StockSEC:0001209191-08-062425:0
    Canonical exit: 18 Feb 2009 (T+90)
  • ▲
    Vice President for ClinicalExecutivesInsulet Corp
    3,590 USD0SEC
    1,000 shares@ US$3.59Common StockSEC:0001209191-08-062425:1
    Canonical exit: 18 Feb 2009 (T+90)
  • ▲
    Vice President for ClinicalExecutivesInsulet Corp
    3,600 USD0SEC
    1,000 shares@ US$3.60Common StockSEC:0001209191-08-062425:2
    Canonical exit: 18 Feb 2009 (T+90)
  • ▲
    Vice President for ClinicalExecutivesInsulet Corp
    3,490 USD0SEC
    1,000 shares@ US$3.49Common StockSEC:0001209191-08-062425:3
    Canonical exit: 18 Feb 2009 (T+90)
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    22,487 USD0SEC
    7,918 shares@ US$2.84Common StockSEC:0001209191-08-057096:0
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    12,431 USD0SEC
    3,453 shares@ US$3.60Common StockSEC:0001209191-08-056195:0
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    7,057 USD0SEC
    1,188 shares@ US$5.94Common StockSEC:0001209191-08-056195:1
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    9,422 USD0SEC
    7,918 shares@ US$1.19Common StockSEC:0001209191-08-055985:0
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    435 USD0SEC
    174 shares@ US$2.50Common StockSEC:0001209191-08-055985:1
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    20,998 USD0SEC
    17,645 shares@ US$1.19Common StockSEC:0001209191-08-008513:0
  • ◇
    Vice President for ClinicalExecutivesInsulet Corp
    9,685 USD0SEC
    3,874 shares@ US$2.50Common StockSEC:0001209191-08-008513:1
  • ▼
    Vice President for ClinicalExecutivesInsulet Corp
    48,000 USD0SEC
    2,000 shares@ US$24.00Common StockSEC:0001209191-08-002733:0
  • ▼
    Vice President for ClinicalExecutivesInsulet Corp
    52,000 USD0SEC
    2,000 shares@ US$26.00Common StockSEC:0001209191-08-002733:1

20 of 20 declarations